Clinical Trial: Rapamycin In Angiomyolipomas In Patients With Tuberous Sclerosis

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: CLINICAL TRIAL TO DETERMINE THE EFFICACY AND SAFETY OF RAPAMYCIN IN ANGIOMYOLIPOMAS IN PATIENTS WITH TUBEROUS SCLEROSIS

Brief Summary: The purpose of this study is to determine whether rapamycin is safe and effective in the treatment of renal angiomyolipomas in patients with tuberousclerosis.

Detailed Summary:
Sponsor: Fundacio Puigvert

Current Primary Outcome: Angiomyolipoma volume [ Time Frame: 2 years ]

Measured by MRI


Original Primary Outcome: Same as current

Current Secondary Outcome: skin lesions, AML complications, [ Time Frame: 2 years ]

Evaluate skin lesions Collect event realted to AML


Original Secondary Outcome: Same as current

Information By: Fundacio Puigvert

Dates:
Date Received: October 6, 2010
Date Started: October 2008
Date Completion:
Last Updated: March 7, 2012
Last Verified: March 2012